From: Sex differences in Sjögren’s syndrome: a comprehensive review of immune mechanisms
• Estrogen activates B cells increasing autoantibodies and ICs, testosterone inhibits B cells decreasing autoantibodies and ICs |
• Some studies report more autoantibodies in women with SS compared to men |
• Exocrine gland inflammation is elevated in women with SS compared to men |
• SS in women is associated with other ADs that occur predominantly in women like RA, thyroiditis, and Raynaud’s phenomenon |
• Lymphoma occurs more frequently in men with SS |
• Most cases of SS occur in women following menopause indicating that, in general, estrogen protects against SS prior to menopause |
• Prolactin released during pregnancy may increase premenopausal SS cases |
• Prolactin acts synergistically with estrogen to increase Ro/SSA and La/SSB |
• Low estrogen levels after menopause continue to elevate autoantibodies |
• Estrogen protects against SS-like disease in animal models |
• The androgen DHEA protects against SS in patients |
• Estrogen and DHEA is decreased following menopause when most SS cases occur |
• Low estrogen levels correlate with dry mouth and ocular dryness |